Geneos Wealth Management’s Autoliv ALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-97
Closed -$10.9K 2497
2025
Q2
$10.9K Sell
97
-511
-84% -$50K ﹤0.01% 2289
2025
Q1
$53.8K Buy
608
+432
+245% +$41.1K ﹤0.01% 1889
2024
Q4
$16.5K Buy
176
+13
+8% +$1.25K ﹤0.01% 1817
2024
Q3
$15.2K Buy
+163
New +$16.2K ﹤0.01% 1663
2023
Q1
Sell
-55
Closed -$4.21K 2043
2022
Q4
$4.21K Hold
55
﹤0.01% 1745
2022
Q3
$3K Buy
+55
New +$4.26K ﹤0.01% 1766
2018
Q4
Sell
-102
Closed -$8K 2379
2018
Q3
$8K Sell
102
-40
-28% -$3.81K ﹤0.01% 1902
2018
Q2
$14K Hold
142
﹤0.01% 1579
2018
Q1
$14K Hold
142
﹤0.01% 1522
2017
Q4
$12K Hold
142
﹤0.01% 1556
2017
Q3
$12K Hold
142
﹤0.01% 1502
2017
Q2
$11K Buy
+142
New +$10.8K ﹤0.01% 1487

Other funds holding ALV

Geneos Wealth Management's ALV Position: Q3 2025 in Review

Geneos Wealth Management sold out of Autoliv (ALV) in Q3 2025, closing a stake of 97 shares — an estimated $10.9K sold.

Geneos Wealth Management first reported a position in ALV in Q2 2017 and held it in 12 quarters. The position peaked at $53.8K in Q1 2025. 382 funds tracked by Wall St. Rank hold ALV as of Q3 2025.

  • Geneos Wealth Management reported no remaining Autoliv position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 97 Autoliv shares in Q3 2025, an estimated $10.9K.
  • Geneos Wealth Management first reported a position in Autoliv in Q2 2017 and held it in 12 quarters.
  • Geneos Wealth Management's Autoliv position peaked at $53.8K in Q1 2025.
  • 382 funds tracked by Wall St. Rank held Autoliv as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.